Prognosis
Moderna Co-Founder Sees Potential for Annual Covid-19 Boosters
- Afeyan sees a time when Covid shots are as regular as the flu
- Company hopes for full U.S. approval for its vaccine in months
This article is for subscribers only.
With governments around the world debating whether to authorize Covid-19 vaccine booster doses, Moderna Inc. co-founder Noubar Afeyan envisions a time when the shot could become routine.
“Public health officials are going to have to decide if everybody should get a booster shot,” he said in an interview on “The David Rubenstein Show: Peer-to-Peer Conversations” that’s airing on Bloomberg TV on Wednesday.